You are here

solid tumors

Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment

Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment

Fierce Biotech

Flag link:

Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead

Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead

Fierce Biotech

PARP inhibitors

Gilead Sciences

Flag link:

Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific

Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific

Fierce Biotech

diabetic retinopathy

bispecific antibodies

Flag link:

Adlai Nortye IPO gives old Novartis cancer drug new life

Adlai Nortye IPO gives old Novartis cancer drug new life

BioPharma Dive

head and neck cancer

Flag link:

1ST Biotherapeutics and Merck to assess cancer combination treatment

1ST Biotherapeutics and Merck to assess cancer combination treatment

Clinical Trials Arena

1st Biotherapeutics

clinical trials

Flag link:

FDA grants clearance to Harbour’s IND for solid tumors therapy trial

FDA grants clearance to Harbour’s IND for solid tumors therapy trial

Clinical Trials Arena

clinical trials

Flag link:

Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors

Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors

BioSpace

KRAS inhibitors

clinical trials

Flag link:

Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T

Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T

BioSpace

Moderna Therapeutics

Flag link:

Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans

Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans

Fierce Biotech

Moderna Therapeutics

Flag link:

Bio-Thera reports positive data from solid tumors therapy trial

Bio-Thera reports positive data from solid tumors therapy trial

Clinical Trials Arena

Bio-Thera Solutions

clinical trials

Flag link:

FDA clears Qualigen’s IND for trial of solid tumour therapy

FDA clears Qualigen’s IND for trial of solid tumour therapy

Clinical Trials Arena

Qualigen Therapeutics

clinical trials

Flag link:

Enhertu offers survival benefits in Phase II solid tumour trial

Enhertu offers survival benefits in Phase II solid tumour trial

Clinical Trials Arena

clinical trials

Flag link:

Roche Decides Not to Exercise Solid Tumor Option with SQZ

Roche Decides Not to Exercise Solid Tumor Option with SQZ

BioSpace

Flag link:

Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure

Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure

Medical Marketing and Media

clinical trials

Flag link:

Xilio reports preliminary data from Phase I solid tumors therapy trial

Xilio reports preliminary data from Phase I solid tumors therapy trial

Clinical Trials Arena

Xilio Therapeutics

clinical trials

Flag link:

UCB partners with Ariceum for treatment of immune-related diseases and cancer

UCB partners with Ariceum for treatment of immune-related diseases and cancer

Biopharma Reporter

radiopharmaceuticals

Flag link:

Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas

Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas

BioSpace

cardiovascular disease

Flag link:

Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear

Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear

Fierce Biotech

Flag link:

FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101

FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101

Clinical Trials Arena

Sensei Biotherapeutics

clinical trials

Flag link:

BMS signs ADC development deal with Munich-based biotech worth more than $1B

BMS signs ADC development deal with Munich-based biotech worth more than $1B

Medical Marketing and Media

Bristol Myers Squibb

antibody-drug conjugate

Flag link:

Pages